Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.
Nakazawa J, Tsuruta N, Shimokawa M, Kawahira M, Arima S, Ido A, Koga F, Ueda Y, Komori A, Otsu S, Fukahori M, Makiyama A, Taguchi H, Honda T, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Otsuka T, Shirakawa T, Mitsugi K. Nakazawa J, et al. Among authors: kawahira m. Oncology. 2023;101(1):22-31. doi: 10.1159/000527176. Epub 2022 Oct 4. Oncology. 2023. PMID: 36195058
Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms.
Iwaya H, Fukukura Y, Hashimoto S, Tanoue S, Kawahira M, Hinokuchi M, Fujita T, Komaki Y, Arima S, Sasaki F, Kanmura S, Higashi M, Tamada K, Ido A. Iwaya H, et al. Among authors: kawahira m. Pancreatology. 2021 Jun;21(4):779-786. doi: 10.1016/j.pan.2021.02.020. Epub 2021 Mar 3. Pancreatology. 2021. PMID: 33714670
Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer: A Multicenter Observational Study (NAPOLEON Study).
Arima S, Kawahira M, Shimokawa M, Ido A, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Fukahori M, Makiyama A, Taguchi H, Honda T, Shibuki T, Mitsugi K, Nio K, Ide Y, Ureshino N, Mizuta T, Shirakawa T, Otsuka T. Arima S, et al. Among authors: kawahira m. Pancreas. 2021 Aug 1;50(7):957-964. doi: 10.1097/MPA.0000000000001859. Pancreas. 2021. PMID: 34347735
Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prospective Comparative Study with Tissue Specimens.
Iwaya H, Tanimoto A, Toyodome K, Kojima I, Hinokuchi M, Tanoue S, Hashimoto S, Kawahira M, Arima S, Kanmura S, Akahane T, Higashi M, Suzuki S, Ueno S, Ohtsuka T, Ido A. Iwaya H, et al. Among authors: kawahira m. Diagnostics (Basel). 2023 Mar 13;13(6):1078. doi: 10.3390/diagnostics13061078. Diagnostics (Basel). 2023. PMID: 36980386 Free PMC article.
Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events.
Kawahira M, Kanmura S, Mizuno K, Machida K, Ohtsuka T, Sato M, Enokida H, Yamashita M, Kanekura T, Arima S, Nakamura N, Sugiura T, Yoshimoto K, Kobayashi H, Ishitsuka K, Suzuki S, Ueno S, Ido A. Kawahira M, et al. PLoS One. 2022 Apr 28;17(4):e0267572. doi: 10.1371/journal.pone.0267572. eCollection 2022. PLoS One. 2022. PMID: 35482642 Free PMC article.
A case of immunoglobulin G4-related sclerosing mesenteritis without other organ involvement.
Kozono M, Tanoue S, Kiyama K, Jikuya K, Kawahira M, Hinokuchi M, Iwaya H, Arima S, Hashimoto S, Hiwatashi K, Fukuda Y, Sakoda M, Higashi M, Tokushige K, Ido A. Kozono M, et al. Among authors: kawahira m. Clin J Gastroenterol. 2021 Oct;14(5):1411-1418. doi: 10.1007/s12328-021-01451-1. Epub 2021 Jun 7. Clin J Gastroenterol. 2021. PMID: 34097250
52 results